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Background: Dioscoreanone (DN) isolated from Dioscorea membranacea Pierre has been reported to exert potent
cytotoxic effects against particular types of cancer. The present study was carried out to investigate the cytotoxicity
of DN against a panel of different human lung cancer cell lines. The study further examined the underlying
mechanisms of its anticancer activity in the human lung adenocarcinoma cell line A549.
Methods: Antiproliferative effects of DN were determined by SRB and CFSE assays. The effect of DN on cell cycle
distribution was assessed by flow cytometric analysis. Apoptotic effects of DN were determined by sub-G1
quantitation and Annexin V-FITC/PI flow cytometric analyses, as well as by changes in caspase-3 activity and relative
levels of Bax and Bcl-2 mRNA.
Results: DN exerted antiproliferative and cytotoxic effects on all three subtypes of non-small cell lung cancer
(NSCLC) cells, but not on small cell lung cancer (SCLC) cells and normal lung fibroblasts. DN slowed down the cell
division and arrested the cell cycle at the G2/M phase in treated A549 cells, leading to a dose- and time- dependent
increase of the sub-G1 population (apoptotic cells). Consistently, early apoptotic cells (AnnexinV +/PI−) were
detected in those cells that were treated for 24 h and increased progressively over time. Moreover, the highest
activity of caspase-3 in DN-treated A549 cells was detected within the first 24 h, and pretreatment with the
general caspase inhibitor z-VAD-fmk completely abolished such activity and also DN-induced apoptosis in a
dose-dependent manner. Additionally, DN increased the Bax/Bcl-2 ratio in treated A549 cells with time, indicating
its induction of apoptosis via the mitochondrial pathway.
Conclusions: This study reveals for the first time that the anticancer activity of DN was induced through regulation
of the Bcl-2 family protein-mediated mitochondrial pathway and the subsequent caspase-3 activation in A549
cancer cells, thus supporting its potential role as a natural apoptosis-inducing agent for NSCLC.
Keywords: Dioscoreanone, Dioscorea membranacea, Antiproliferative, Apoptosis, Caspase activationBackground
Lung cancer is a leading cause of cancer-related deaths
worldwide [1], and it can be divided into two histological
groups: non-small cell lung cancer (NSCLC) and small
cell lung cancer (SCLC). NSCLC accounts for almost
80% of lung cancer cases and consists mainly of adenocar-
cinoma, squamous cell and large cell carcinoma. Although
many factors, e.g., tobacco smoke, ionizing radiation and* Correspondence: hansakul@gmail.com
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unless otherwise stated.viral infection are known to increase the risk of this cancer
type, the mechanisms involved in lung cancer formation
remain largely unknown to date [2]. Despite improve-
ments in tumor response to chemotherapy, the overall sur-
vival rate for lung cancer patients in advanced or late
stages of the disease is still low and has not improved sig-
nificantly in recent past decades [1]. Because of the muta-
tion heterogeneity of lung cancer cells associated with
acquired drug resistance, the search for novel anticancer
agents with an enhanced specificity for cancer cells re-
mains an urgent need in order to increase the potency of
chemotherapy [3]. Herbal medicines in the treatment ofal Ltd. This is an Open Access article distributed under the terms of the Creative
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portant source for such agents, some of which are cur-
rently used in clinical practice [4]. In recent years,
plant-derived compounds have been extensively screened
to explore their potential for the development of new anti-
cancer drugs.
Exploring the precise molecular mechanisms involved in
actions of anticancer agents has become an important ap-
proach for anticancer drug evaluation and development.
Among these molecular mechanisms, apoptosis is a highly
regulated process of cell death that serves to eliminate
heavily damaged cells without injuring surrounding
healthy cells, and its dysregulation underlies numerous
pathological conditions including cancer [5]. Over the
years, apoptosis has emerged as the major mechanism
by which anticancer agents act to eliminate cancer cells
[6]. Recent clinical data have revealed that anticancer
drugs that restore deregulated apoptosis or apoptosis-
related signaling pathways in cancer cells can signifi-
cantly improve patient survival for patients who have
contracted various advanced cancer diseases [7]. In this
context, several plant compounds have been proven, in
a more specific manner, to possess promising antican-
cer activity through their apoptosis-inducing effects [8].
Dioscoreanone (DN) is 1, 4-Phenanthraquinone (Figure 1)
isolated from the ethanolic extract of dried rhizomes of
Dioscorea membranacea Pierre [9], which has long been
used in various traditional Thai herbal remedies for cancer
and inflammatory diseases. Previous studies have shown
the selective anticancer and anti-inflammatory activities of
this herbal plant [10,11], providing the scientific support for
its traditional uses. Moreover, DN was demonstrated to
exert selective cytotoxic effects against human lung and
breast cancer cell lines, but not against normal cells [9].
However, the molecular mechanisms underlying its cyto-
toxicity have not yet been explored.Figure 1 Structure of dioscoreanone (DN).In the present study, we first examined dose–response
growth inhibitory and cytotoxic effects of DN on lung can-
cer cells including NSCLC and SCLC versus normal
human lung fibroblasts. We further investigated apoptosis-
involved mechanisms underlying the anticancer activity of
DN in human lung adenocarcinoma A549 cells.
Methods
Dioscoreanone preparation
Rhizomes of Dioscorea membranacea Pierre ex Prain &
Burkill were extracted with 95 % ethanol to obtain crude
extract as previously mentioned [11]. This plant was col-
lected from Amphoe Patue, Chumphorn Province. Au-
thentication of plant material was carried out at the
herbarium of the Department of Forestry, Bangkok,
Thailand (Voucher number SKP A062041305). Dioscorea-
none (DN) was isolated from the crude ethanolic extract
using previously described methods [10]. The structure of
DN (Figure 1) was confirmed by comparing its structure
with previously reported 1H- and 13C-NMR spectral data
[9]. The stock solution of DN was prepared in DMSO at a
concentration of 35 mM. The final concentration of
DMSO was at or below 0.1% in all experiments.
Cell culture
Five cell lines were purchased from American Type
Culture Collection (ATCC; Rockville, MD, USA), namely
three subtypes of human non-small cell lung cancer
(NSCLC) consisting of A549 (adenocarcinoma), COR-
L23 (large cell carcinoma), and NCI-H226 (squamous
cell carcinoma); human small cell lung cancer (SCLC) in
the form of NCI-H1688; and human normal lung fibro-
blasts as MRC-5. All cancer cell lines were maintained
in RPMI-1640 supplemented with 10% FBS, and MRC-5
cells were cultured in MEM supplemented with 10%
FBS, 1 mM nonessential amino acid, and 1% sodium
pyruvate at 37°C in 5% CO2 incubator.
Cell proliferation assay
Antiproliferative effects of DN were measured by the
SRB assay. Briefly, cells were seeded in a 96-well plate
containing 100 μl of culture medium. Cell numbers are
indicated in the bracket (A549 = 1 × 103 cells/well;
COR-L23 and NCI-H226 = 3 × 103 cells/well; NCI-
H1688 and MRC-5 = 2 × 104 cells/well). On the follow-
ing day, one plate of each cell line was fixed in situ with
100 μl of 10% (w/v) cold trichloroacetic acid (TCA), and
it was stained with 0.4% (w/v) sulforhodamine B (SRB)
in 1% acetic acid solution as a means of representing the
cell number at the time of adding DN (zero hour). One
hundred microliters of DN was added to the tested
plates to obtain final concentrations of 0.35, 3.5, 17.5
and 35 μM, and these plates were incubated for add-
itional 72 h at 37°C with 5% CO2. At the end of 72 h,
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fixed with 10% (w/v) cold TCA. The cell numbers were
estimated indirectly by staining the total cellular protein
content of each well with 0.4% (w/v) SRB. The optical
density (O.D.) was measured at 492 nm. The percentage
of cell survival for each concentration was calculated
using the following formula:
% cell survival ¼ T − T0ð Þ= C − T0ð Þ½   100; T≥T0
or
¼ T − T0ð Þ= T0½   100⋯⋯; T < T0
where T is the average O.D. of cells treated with DN for
72 h; T0 is the average O.D. at 0 h; C is the average O.D
of cells treated with media only for 72 h. Based on the
formula, the percentage of cell survival can be greater
than zero, zero or less than zero. Dose–response curves
were plotted as percentage of cell survival versus DN
concentration. The concentrations of DN required for
50% growth inhibition (GI50), total growth inhibition
(TGI), and 50% loss of cells (lethal concentration, LC50)
relative to the untreated cells were obtained by interpol-
ating dose–response curves with cubic spline using
GraphPad Prism 4.0 Software (GraphPad Software, Inc.,
USA).
CFSE proliferation assay
Carboxyfluorescein diacetate, succinimidyl ester (CFDA-
SE) is a cell-tracking dye used to label cells for exa-
mining their proliferative activity. It diffuses into the
cytoplasm where its acetate groups are cleaved to yield a
highly fluorescent derivative (CFSE) that is retained in
the cell. A profile of sequential halving of CFSE fluores-
cence intensity with each generation can be monitored,
allowing the visualization of the number of rounds of
cell division. Inhibition of cell division by any substance
can thus be traced through changes in CFSE profile. In
the assay, detached A549 cells were labeled with 10 mM
carboxyfluorescein-succinimidyl ester (CFSE) (BD bio-
science, USA) at 37°C for 20 min in the dark and washed
twice with PBS containing 10% FBS (FACS buffer) to re-
move excess CFSE. Cells were plated at 1 × 105 cells/
well in 24-well plates and incubated at 37°C with 5%
CO2. At least 12 h after seeding, 30 μM dioscoreanone
was added into each well, and the cells were further in-
cubated for 24, 48 and 72 h. At the appropriate point in
time, cells were detached, washed twice, re-suspended in
FACS buffer, and analyzed immediately using a FACSCa-
libur flow cytometer (Becton Dickinson, USA). Numbers
of cell division as well as two parameters, e.g. prolifera-
tion index and precursor frequency, were analyzed using
ModFit LT 3.2 program (Verity Software House, USA).
Proliferation index was calculated as the sum of cells inall generations divided by the number of original parent
cells; this index is useful for determining antiproliferative
effects of DN on a population of cells. On the other
hand, precursor frequency was calculated as the percent-
age of cells in the original parent population that prolif-
erated in response to DN.
Cell cycle analysis
The percentage of cells in sub-G1 (apoptotic cells), G1, S
and G2/M phases was determined by DNA flow cytome-
try. Briefly, A549 cells were plated at 1 × 105 cells/well in
24-well plates and incubated with 15 μM and 30 μM DN
for 24, 48 and 72 h at 37°C with 5% CO2. After treatment,
cells were collected by trypsinization, fixed gently (drop by
drop) in 80% ethanol, and then stored at −20°C overnight.
Then, cells were washed with phosphate-buffered saline
(PBS) and stained with 0.5 ml PI/RNase staining buffer
(BD bioscience, USA) for 30 min at room temperature in
the dark. These stained cells were collected using a FACS-
Calibur flow cytometer (Becton Dickinson, USA) and ana-
lyzed for cell cycle phases with ModFit LT 3.2 Software
(Verity Software house, USA). Cell cycle distribution was
also determined in DN-treated cells after pretreatment for
1 h with the pancaspase inhibitor z-VAD-fmk, which was
added to final concentrations of 2.5 and 25 μM.
Annexin-V/PI double staining assay
Flow cytometry was used to discriminate between intact
and apoptotic cells. A549 cells were stained with fluores-
cein isothiocyanate (FITC) labeled annexinV that binds
to membrane phosphatidylserine and with propidium
iodide (PI) that binds to cellular DNA according to
the manufacturer’s instructions (BD bioscience, USA).
Briefly, A549 cells were plated at 1 × 105 cells/well in
24-well plates. After exposure to 15 μM and 30 μM DN
for 24, 48 and 72 h, cells were trypsinized, washed with
cold PBS, and resuspended in 100 μl of binding buffer
containing 5 μl of FITC Annexin V and 5 μl of PI. Then
cells were gently vortexed and incubated for 20 min at
room temperature in the dark. Four hundred microliters
of binding buffer was added to each tube. Cells were
then collected using a FACSCalibur flow cytometer
(Becton Dickinson, USA) and analyzed with CellQuest
Software (BD bioscience, USA).
Caspase-3 activity assay
Activity of caspase-3 was detected using the CaspACE™
Assay System (Promega, USA). Briefly, A549 cells were
plated at 1 × 105 cells/well in 24-well plates. After ex-
posure to 30 μM DN for 24, 48 and 72 h, control or
treated cells were lysed in 50–100 μl of cold lysis buffer
by sonication, and the mixture was incubated on ice for
another 20 min. The cell lysates were centrifuged at
15,000 × g for 20 min at 4°C, and the supernatant
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total volume of 100 μl in 96-well plates. Cell extracts
with an equal amount of protein (50–100 μg of total
protein) were added to each reaction containing caspase
assay buffer and specific colorimetric substrate (DEVD-
pNA) for caspase-3, and the mixture was incubated at
37°C for another 4 h according to the manufacturer’s
protocol. The absorbance was measured at 405 nm.
Caspase-3 activity was also measured in cell extracts
treated with DN after pretreatment for 1 h with the pan-
caspase inhibitor z-VAD-fmk, which was added to a final
concentration of 25 μM.
Real-time Quantitative PCR Analysis
After exposure to 30 μM DN for 24, 48 and 72 h, total
RNA was isolated from A549 cells using the total RNA ex-
traction kit (Real Biotech Corporation, Taiwan). Two hun-
dred and fifty nanograms of input total RNA was
converted to single-stranded cDNA using High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
USA). Bcl-2 and Bax gene expression analyses were per-
formed using the Applied Biosystems (ABI) StepOne™ and
StepOne Plus™ Real-Time PCR System (The Applied Bio-
systems, USA) as well as commercially available primer/
probe sets, which are pre-designed FAM™ dye-labeled Taq-
Man® MGB (minor groove binder) probe and primer sets
(inventoried Taqman® Gene Expression Assays) for human
BCL2, BAX and GAPDH genes. The thermal cycling pa-
rameters were one cycle of 50°C for 2 min, one cycle of
95°C for 10 min, 40 amplification cycles of 95°C for 15 sec,
and 60°C for 1 min. Relative quantification of gene expres-
sion was performed using the comparative threshold (CT)
method according to the 2-ΔΔCT method as described by
the manufacturer. The CT values of target genes (Bcl2 and
Bax) in each sample set (ΔCT test sample) were normal-
ized to those of GAPDH. The ΔΔCT is calculated by the
formula ΔΔCT =ΔCT test sample – ΔCT control. ΔΔCT
was converted to fold changes in mRNA gene expression
relative to control by the equation 2-ΔΔCT. The fold
changes are presented as the mean ± SD.
Statistical analysis
All experiments were performed independently at least
three times, and the results were expressed as the mean ±
SD. Statistically significant differences among the groups
were analyzed by one-way analysis of variance (ANOVA),
followed by post-hoc analysis. p value <0.05 was consid-
ered statistically significant (SPSS 16.0 for Windows).
Results
The antiproliferative and cytotoxic effects of DN in
several lung cancer cell lines
In this study, we further evaluated the antiproliferative
effect of DN in two major types of human lung tumor-derived cell lines versus the human lung fibroblast cell line
MRC-5. These two major types were NSCLC cell lines that
included three main subtypes, namely A549 (adenocarcin-
oma), COR-L23 (large cell carcinoma), and NCI-H226
(squamous cell carcinoma), as well as a SCLC cell line,
NCI-H1688. Our results showed that DN in the concen-
tration range of 0.35-35 μM exerted a significant dose-
dependent inhibition of cell growth in all cell lines tested.
As a result, the concentrations of DN required for 50%
growth inhibition (GI50), total growth inhibition (TGI),
and 50% loss of cell numbers (lethal concentration, LC50)
at 72 h were thus able to be assessed as shown in Table 1.
Paclitaxel was also used as a positive control.
DN exhibited a significant growth-inhibitory effect in all
three subtypes of NSCLC cell lines with GI50 values ran-
ging from 3.7 to 6.2 μM, as compared to NCI-H1688 and
MRC-5 cells. At high concentrations of DN, the represen-
tatives of each subtype of NSCLC −A549, COR-L23 and
NCI-H226 cell lines also showed the negative values of cell
survival presented as LC50, thus indicating a net loss of
cancer cells. Altogether, these data revealed that DN
exerted selective antiproliferative activity (growth in-
hibition) and cytotoxic activity (cell death induction)
against these NSCLC cancer cells.
In contrast to DN, paclitaxel showed a very strong an-
tiproliferative activity with ~140-1270-fold higher GI50 and
TGI values in all tested cell lines (except NCI-1688). How-
ever, paclitaxel appeared to exert selective growth inhibi-
tory effects on NSCLC cancer cells but high cytotoxicity
on human normal lung fibroblasts. Therefore, DN has
potential as a promising anticancer agent because of its
selective antiproliferative and cytotoxic activities without
harming normal cells. Several studies described below
were performed to provide insights into the molecular
mechanism(s) underlying the anticancer activity of DN.
The antiproliferative activity of DN in adenocarcinoma
A549 cells
As DN exhibited a growth inhibitory effect against all
three subtypes of NSCLC with no statistical difference,
we chose the adenocarcinoma cell line A549 to further
investigate molecular mechanisms of DN’s antiproliferative
and cytotoxic effects. The reason is that adenocarcinoma
is the most common subtype, making up of 30-40% of all
types of lung cancer. Unlike traditional methods of meas-
uring cell proliferation, the CFSE cell division assay was
employed to detect the cell division arrest induced by DN
in A549 cells.
As CFSE fluorescence intensity is reduced by one half
at each cell division, the proliferation of CFSE-labeled
cells either untreated or treated with DN can be moni-
tored through such fluorescence intensity. Flow cytomet-
ric analysis of CFSE-labeled cells exposed to 30 μM DN
using ModFit LT 3.2 program (Verity Software House,
Table 1 Cytotoxic effects of dioscoreanone (DN) on human lung cell lines
Cell line Lung cell type Paclitaxel (μM) DN (μM)
GI50 TGI LC50 GI50 TGI LC50
MRC-5 Normal lung fibroblast 0.016 ± 0.005 0.297 ± 0.008 >32 11.4 ± 1.3 19.6 ± 0.7 >32
3 subtypes of NSCLC
A549 Adenocarcinoma 0.016 ± 0.001 0.058 ± 0.012 2.800 ± 0.400a 6.2 ± 0.7a 10.3 ± 0.3a 15.7 ± 1.3a
NCI-H226 Squamous cell carcinoma 0.017 ± 0.001 4.898 ± 0.480a 20.672 ± 0.436a 5.7 ± 1.2a 9.8 ± 0.3a 13.6 ± 1.2a
COR-L23 Large cell carcinoma 0.017 ± 0.001 3.450 ± 0.167a 17.725 ± 0.084a 3.7 ± 0.9a 8.0 ± 1.4a 18.9 ± 2.5a
NCI-1688 SCLC 0.012 ± 0.001 20.560 ± 0.147a >32 15.2 ± 2.1 21.1 ± 2.4 >32
DN concentrations required for 50% growth inhibition (GI50), total growth inhibition (TGI), and 50% decrease in cell numbers (LC50) relative to the untreated cells
as measured by the SRB assay. Data are presented as the mean ± SD of at least 3 independent experiments.
aStatistical significance (p <0.05) versus MRC-5.
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of daughter cells with respect to untreated cells, indicat-
ing cell division arrest (Figure 2A). Evidently, the growth
inhibitory effect of DM started from 24 to 48 h-long
treatments. Moreover, the proliferation index of un-
treated cells reached approximately 2, 4 and 8 at 24, 48
and 72 h, respectively whereas the index values of DN-
treated cells slightly increased in those time periods
(Figure 2B). By 72 h, the proliferation index of these
treated cells reached only 25% of that of untreated cells.
Additionally, the untreated parental cells divided vigor-
ously, resulting in substantial increases in precursor fre-
quency that reached 75.3% after 72-h incubation. In
contrast, only 13.6% of DN-treated parental cells under-
went at least two rounds of cell division after 72 h, indi-
cating that cell division greater than 85% of the A549
cells was hindered. Altogether, the results revealed DN-
induced cell division arrest.
The inhibitory effect of DN on cell cycle progression in
A549 cells
The effect of DN on cell cycle distribution was next
assessed by flow cytometry. Significant alterations in the
percentage of cells were observed in nearly all G1, S and
G2/M phases of A549 cells treated with 15 μM and
30 μM DN (Figure 3) for 24, 48 and 72 h. In particular,
the percentage of cells in the G2/M phase increased to
the highest level in a 48-h treatment, thus indicating
DN-induced G2/M-phase arrest. Such arrest was associ-
ated with a concomitant decrease in the percentage of
cells in the G1 phase. Moreover, sub-G1 accumulation
was observed in a dose- and time-dependent manner.
The sub-G1 population was regarded as apoptotic cells
containing only fractional DNA content. By 72 h, a
marked increase in sub-G1 population in 30 μM DN treat-
ment (~27% sub-G1) was accompanied by a decrease in
the percentage of cells in the G2/M phase (Figure 3).
These results indicated that the cell death was subsequent
to the growth arrest. These results demonstrated that DN
exerted its antiproliferative effect through cell cycle arrestat the G2/M phase and its cytotoxic effect through apop-
totic death.
Annexin V-FITC flow cytometric analysis of apoptotic ef-
fects of DN in A549 cells
It was noted that cell cycle analysis first revealed the
presence of apoptotic cells in DN-treated cells apart
from G2/M-phase arrest. Thus, the next step in this
study was to test whether apoptosis was indeed initiated
in DN-treated cells. As translocation of phosphatidylser-
ine (PS) to the external membrane leaflet is one of the
earliest features of apoptosis, early apoptotic cells can
thus be identified by the Annexin-V-FITC/PI double stain-
ing assay. Besides, double staining with PI allows differen-
tiation of early apoptotic cells with intact membrane
(AnnexinV +/PI−) from late apoptotic/necrotic cells with
leaky membranes (AnnexinV+/PI+) and normal cells
(AnnexinV−/PI−). As a result, the different groups of these
stained cells can be distinguished and quantified by flow
cytometry.
The Annexin-V-FITC/PI double staining assay indi-
cated that DN induced a decrease in the percentage of
viable cells (lower-left, LL) with a concomitant increase
in percentage of early apoptotic cells (lower-right, LR)
and late apoptotic cells (upper-right, UR) as compared
to untreated cells (Figure 4A, B) in a dose- and time-
dependent manner. However, the time-dependent effect
of DN was significantly observed in 30 μM DN treat-
ment, which significantly induced approximately 40%
and 50% of early and late apoptotic cells combined at 48 h
and 72 h, respectively (Figure 4A, B). These results con-
firmed that DN plays a critical role in triggering apoptotic
cell death in DN-treated A549 cells. Notably, the increased
early and late apoptotic cell populations were accompanied
with the increased sub-G1 population in the cell cycle
analysis after 48 and 72-h incubation of 30 μM DN.
Effect of DN on caspase-3 activity in A549 cells
Caspases, a family of cysteine-aspartic proteases, are
known to be crucial mediators in the apoptotic-signaling
AB
Figure 2 Flow cytometric analysis of cell division by dilution of CFSE. (A) CFSE histograms of control A549 cells (top) and DN-treated A549
cells (bottom) for 24, 48 and 72-h incubation period. A profile of sequential halving of CFSE fluorescence intensity with each generation was
monitored, and numbers of cell division were analyzed using ModFit LT 3.2 program. (B) Proliferation index (left) and precursor frequency (right)
of untreated and DN-treated A549 cells. Each bar graph represents the mean ± SD of at least three independent experiments. *Statistical significance
(p <0.05) versus control.
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in DN-induced apoptosis, A549 cells were pretreated for
1 h with the pancaspase inhibitor z-VAD-fmk at 2.5 μM or
25 μM prior to the addition of 30 μM DN for 72 h and
were measured for the subG1 population. The results dem-
onstrated that z-VAD-fmk decreased the population of
apoptotic cells according to its concentrations (Figure 5).
Indeed, 25 μM z-VAD-fmk was sufficient to completely
abolish DN-induced increase in the sub-G1 cells, thus indi-
cating that caspases play a role in DN-induced apoptosis.
As caspase-3 is well established as the major execu-
tioner caspase and its activation ultimately leads to cell
death [13], it is thus suited as a read-out in an apoptosis
assay. We next evaluated whether DN-induced apoptosis
is associated with changes in caspase-3 activity. A549
cells treated with 30 μM for 24 h, 48 h and 72 h were
analyzed for such activity using in vitro colorimetricsubstrate DEVD-pNA. Thirty μM DN was chosen be-
cause it induced prominent apoptotic effects. The results
in Figure 6A showed a time-dependent activation of
caspase-3. Its activity reached a maximum level within
24 h, then decreased over time, and was found to be not
significantly different from the control at 72 h. On the
contrary, the cell cycle results in the previous section re-
vealed a maximum of ~27% apoptotic cells (sub-G1
peak) at 72 h (Figure 3). All these results indicated that
the DN-induced caspase-3 activation started to increase
many hours before a large population of apoptotic cells
was observed. Pretreatment of A549 cells with 25 μM
z-VAD-fmk prior to the addition of DN significantly de-
creased the caspase-3 activity to the same level as the
control cells (Figure 6B). These results indicated that the
DN-induced apoptosis was indeed triggered by the acti-
vation of caspase-3 in A549 cells.
Figure 3 Cell cycle distributions of DN-treated A549 cells by flow cytometric analysis. A549 cells were either untreated or treated with
15 μM DN or 30 μM DN for 24, 48 and 72 h, then fixed, stained with PI, and analyzed by flow cytometry. Representative histograms from one of
at least three independent experiments are shown. The percentages of cells in sub-G1, G0/G1, S and G2/M phases were analyzed using ModFit
LT 3.2 program and indicated. *Statistical significance (p <0.05) versus control at equal incubation periods.
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proteins in A549 cells
The Bcl-2 family proteins, which include pro-apoptotic
Bax and anti-apoptotic Bcl2 proteins, have been reported
to regulate mitochondrial membrane permeabilization
(MMP), which subsequently triggers apoptotic pathways
[14]. To determine whether such members are engaged
in DN-induced apoptosis, the relative mRNA expression
of Bax and Bcl2 was assessed by real-time quantitative
RT-PCR. The results demonstrated that 30 μM DN caused
Bax mRNA levels in treated A549 cells to increase over 3-
fold and 2-fold at 48 h and 72 h, respectively (Figure 7).
Similarly, Bcl2 mRNA expression increased nearly 2-fold
after treatment of 30 μM DN for 48 h. However, it was no-
ticeable that relative fold increases in the Bax mRNA level
were higher than those in the Bcl2 mRNA level. At
72 h, the level of Bcl2 mRNA reduced to the same levelas the control. Therefore, the increased Bax levels and
the reduced Bcl2 levels caused high Bax/Bcl2 ratios
(greater than 1) in a time-dependent manner, indicating
DN-induced apoptosis via regulation of the Bcl-2 family
protein-mediated mitochondrial pathway.
Discussion
DN potentially exerted dose-dependent antiproliferative
(described as GI50 and TGI values) and cytotoxic effects
(represented as LC50 values) only on the three subtypes
of NSCLC cell lines, but not on the SCLC cell line. The
differential sensitivity of these cancer cells to DN could
be explained in part because of their distinctive molecu-
lar characteristics [3]. Studies on molecular mechanisms
of DN in regard to its antiproliferative effect revealed
significantly low proliferation index and precursor fre-
quency values in DN-treated A549 cells via G2/M-phase
AB
Figure 4 (See legend on next page.)
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Figure 4 Detection of apoptosis in DN-treated A549 cells by Annexin V-FITC flow cytometric analysis. A549 cells were either untreated or
treated with 15 μM DN or 30 μM DN for 24, 48, and 72 h, then stained with PI and AnnexinV-FITC, and measured by flow cytometry. (A) Representative
dot plots from one of at least three independent experiments with the percentages of early apoptotic cells are shown. (B) Bar graphs with percentages
of cells in the respective quadrants are indicated. LL: Viable cells, LR: Early apoptotic cells, UR: Late apoptotic cells, UL: Dead cells. *Statistical significance
(p <0.05) versus control at equal incubation periods.
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to mediate such G2/M phase arrest in cancer cells through
multiple mechanisms: downregulation of CDK1-cyclin
A/B complexes, inactivation of Cdc25C activity, and dis-
ruption of tubulin polymerization and spindle assembly
[15,16]. In this regard, the effects of DN on the types and
levels of these key regulators need to be identified.
In addition to the antiproliferative effect, significant net
loss of cell viability in NSCLC cells at high concentrations
of DN in the SRB assay indicated its cytotoxic effect. Such
data is in accordance with the results obtained by flow cy-
tometric analysis, which determined the presence of apop-
totic cells reflected by the sub-G1 DNA peak and early
(AnnexinV +/PI−) and late (AnnexinV+/PI+) apoptotic cellsA B
C
Figure 5 Suppression of DN-induced apoptosis by the general caspas
least three independent experiments depict cell cycle distributions. Distribu
treated with 30 μM DN or pretreated for 1 h with (C) 2.5 μM or (D) 25 μM
and further incubation for 72 h. The sub-G1 peaks (blue peaks) on DNA con
in sub-G1, G1, S and G2/M phases are listed.in DN-treated A549 cells. In this context, Annexin V is a
recombinant PS-binding protein that interacts strongly
and specifically with PS residues and is typically used in
conjunction with PI to distinguish early from late apop-
totic cells [17]. All these findings demonstrated apoptosis-
involved mechanisms underlying cytotoxicity of DN for
the first time. Although both late apoptotic and necrotic
cells are Annexin V and PI-positive, the presence of
these cells with early apoptotic cells suggests that such
dead cells resulted from an apoptotic process rather
than a necrotic process.
The apoptotic caspases appear to be activated in a prote-
ase cascade in which the activated apical caspases respon-
ding to apoptotic stimuli directly activate the executionerD
e inhibitor z-VAD-fmk. Representative histograms from one of at
tions are shown in (A) for untreated A549 cells or in (B) for A549 cells
pancaspase inhibitor z-VAD-fmk prior to the addition of 30 μM DN
tent histograms represent apoptotic cells and the percentages of cells
AB
Figure 6 Measurement of caspase-3 activity in DN-treated A549 cells. (A) A549 cells were treated with 30 μM DN for 24, 48 and 72 h.
(B) A549 cells were treated with 30 μM DN for 24 h or pretreated for 1 h with 25 μM z-VAD-fmk inhibitor prior to the addition of 30 μM DN and
further incubation for 24 h. After these treatments, cell lysates were prepared, and enzymatic activities of caspase-3 were measured by the CaspACE™
colorimetric assay. Each bar graph represents the mean ± SD of at least three independent experiments. The caspase-3 activities in untreated cells are
taken as 1-fold, and the figures on the chart display the relative changes of these activities in the treated cells. *Statistical significance (p <0.05) versus
control at equal incubation periods.
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Among these effector caspases, caspase-3 plays a central
role in the execution phase of both the intrinsic (the
mitochondrial) and extrinsic (the death receptor) pathways
of apoptosis by cleaving many key cellular proteins, such
as poly (ADP ribose) polymerase (PARP), inhibitor of
caspase-activated DNase (ICAD), and various other pro-
teins [19]. This cleavage mediates disassembly of the cell
into the typical apoptotic morphological changes, such as
cell shrinkage, chromatin condensation, membrane bleb-
bing, and DNA fragmentation [5]. In this study, the pan-
caspase inhibitor z-VAD-fmk, which irreversibly binds toand blocks the cleavage site of the caspases, was able to
completely abrogate the DN-induced increase in the sub-
G1 cell population and DN-induced activation of caspase-
3 in A549 cancer cells. These results strongly indicated
that DN-induced apoptosis was executed mainly through
a caspase-dependent pathway. In addition to such a path-
way, the execution of apoptosis also constitutes a caspase-
independent pathway that is mediated by mitochondrial
proteins AIF [20] and EndoG [21].
Pro-apoptotic (e.g. Bax) or anti-apoptotic (e.g. Bcl-2)
proteins of the Bcl-2 family, a group of structurally related
proteins, play a critical role in regulating the permeability
Figure 7 Relative mRNA levels of Bax and Bcl-2 in DN-treated A549 cells. A549 cells were treated with 30 μM DN for 24, 48 and 72 h. Total
RNA was isolated and converted to single-stranded cDNAs, which were then quantified by real-time PCR using TaqMan probe and primer pairs
pre-designed for Bax, Bcl-2 and GAPDH as an endogenous control. Relative mRNA levels of Bax, Bcl-2 and Bax/Bcl-2 ratios in treated A549 cells
versus untreated cells are expressed as the mean ± SD of at least three independent experiments. *Statistical significance (p <0.05) versus control
at equal incubation periods.
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deed, an increase in the ratio of Bax/Bcl-2 causes the
permeabilization of OMM, leading to a hierarchical re-
lease of the apoptogenic proteins such as cytochrome c,
Smac/Diablo and Omi/HtrA2, and subsequently result-
ing in downstream caspase-3 activation [22,23]. In-
creases of Bax/Bcl-2 ratio in this study suggest that the
susceptibility of DN-treated A549 cells to apoptosis
could be modulated, at least in part, through the mito-
chondrial pathway.
Besides new insights on the anticancer mechanisms of
DN, understanding its bioavailability when consumed
per ounce (oz) also helps determine the amount of DN
to be taken orally in compliance with the DN concentra-
tions examined in this study. However, no such data are
available, and in vivo oral bioavailability of DN needs to
be further evaluated.
Conclusions
In this study, DN selectively inhibited the growth of
A549, COR-L23 and NCI-H226 representative cell
lines for each of three subtypes of NSCLC. In adeno-
carcinoma A549 cells, DN induced G2/M-phase cell
cycle arrest and apoptosis, at least in part, via mito-
chondrial membrane permeabilization mediated by
Bax and Bcl-2 proteins, leading to caspase-3 acti-
vation. The present study greatly contributes to the
understanding of the anticancer activity of DN for
the first time and also provides evidence that DNdeserves additional evaluation as a natural anticancer
agent for human NSCLC.
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